Carlo Russo

Company: Genenta science

Job title: CMO - Chief Medical Officer& Head of Development

Seminars:

Macrophage Derived Immunotherapy in Glioblastoma to Reprogram the Tumor Microenvironment 10:45 am

Developing cell & gene therapy for solid tumors Reprogramming the tumor microenvironment (TME) using hematopoietic progenitor stem cells Designing combination I/O treatments taking advantage of the agnostic nature of the technology platformRead more

day: Conference Day 1